VaramirStart free · no cardSign in
VERA as of Oct 31 · 07:30 ET
VERANasdaqPharmaceutical Preparations

Vera Therapeutics, Inc. · Brief

Next report

4 days

Nov 4 · before openest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
1 of 8≥ implied
avg implied
±13.0%
avg realized
±3.5%
Nov 7 '24±11.3%▲+2.29%×0.20
Feb 26 '25±16.4%▲+2.47%×0.15
May 6 '25±12.3%▼−13.79%×1.12
Aug 5 '25±6.8%▲+0.93%×0.14
Q3 FY25±21.3%▼−1.03%×0.05
Q1 FY26±14.7%▲+1.61%×0.11
May 7 '26±8.7%▼−1.95%×0.22
Q2 FY26±12.4%▼−4.08%×0.33
quarterimplied−25%0+25%realized×
Q2 FY26±12.4%▼−4.08%×0.33
May '26±8.7%▼−1.95%×0.22
Q1 FY26±14.7%▲+1.61%×0.11
Q3 FY25±21.3%▼−1.03%×0.05
Aug '25±6.8%▲+0.93%×0.14
May '25±12.3%▼−13.79%×1.12
2 older reports
Feb '25±16.4%▲+2.47%×0.15
Nov '24±11.3%▲+2.29%×0.20
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 4 report · est.

Bull2 of 4

4disclosed supplier and customer ties in SEC filingsSEC filings
4tracked funds holding VERAN-PORT · Aug 31 '26

Bear2

7 of 8recent reports where the move came in under the options implied rangeEarnings history
4 of 24largest reporting managers that cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

VERA report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 21impliedImplied move: ±13.5% into Nov 4 earnings (Oct 21 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.